STK11 and KEAP1 mutations as prognostic biomarkers in an observational real-world lung adenocarcinoma cohort

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1Correction: KEAP1 loss modulates sensitivity to kinase targeted therapy in lung cancer2017 · 28 citations
2. 2STK11/LKB1 Deficiency Promotes Neutrophil Recruitment and Proinflammatory Cytokine Production to Suppress T-cell Activity in the Lung Tumor Microenvironment2016 · 634 citations
3. 3Clinical and Pathological Characteristics of <i>KEAP1</i> - and <i>NFE2L2</i> -Mutated Non–Small Cell Lung Carcinoma (NSCLC)2018 · 168 citations
4. 4KEAP1 loss modulates sensitivity to kinase targeted therapy in lung cancer2017 · 160 citations
5. 5Different prognostic impact of<i>STK11</i>mutations in non-squamous non-small-cell lung cancer2015 · 88 citations